On August 3, 2022, this year's Fortune Global 500 list was officially released. It is worth noting that GPHL's performance is still outstanding, and it has been on the list for the second year in a row. After becoming the first Fortune 500 company with Chinese medicine as its main business last year, it has reached a new high this year, ranking 467th, up one place from last year, and its international influence is constantly improving. In the previous list released by Brand Finance, GPHL ranked 18th among the most valuable pharmaceutical brands in the world with a brand value of US$ 2.1 billion, which was one place higher than last year, and its brand value growth rate ranked among the top pharmaceutical brands in China.